|
|
||||||||
1From the Division of Gene Therapy, University of Ulm, Ulm, Germany; 2Department of Experimental Vitreo-Retinal Surgery, University of Tübingen, Tübingen, Germany; and the 3Center of Ophthalmology, Department of Vitreo-Retinal Surgery, University of Cologne, Cologne, Germany.
| Abstract |
|---|
|
|
|---|
METHODS. Laser spots were applied to the fundus of Long-Evans rats. Ten days after, four different methods were used to detect laser-induced neovascularization: (1) high-resolution angiography with fluorescein isothiocyanate-dextran, (2) immunohistochemical visualization of platelet endothelial cell adhesion molecule (PECAM)-1, (3) visualization of intravascular lumens by peroxidase perfusion in the living rat with subsequent histologic analysis, and (4) histochemical representation of alkaline phosphatase in endothelial cells.
RESULTS. At the rim of the laser scars vessel-forming endothelial cells with intravasal dextran and peroxidase were present. Cross-sections demonstrated that these vessels originated from the retina. The center of the scars contained homogenous endothelial cells of choroidal origin, which was confirmed by immunohistochemistry and electron microscopy. In laser-treated eyes without FITC-dextran perfusion, scars showed unspecific fluorescence, making differentiation from specific FITC-dextranassociated fluorescence difficult.
CONCLUSIONS. In the rat model of laser-induced neovascularization, newly developed endothelial cells originate from the retina and the choroid. Whereas ring-like surrounding vessels come from the retina, flat endothelial cells in deeper layers are of choroidal origin or may originate from circulating endothelial precursor cells. Dextran angiography has to be regarded critically for visualizing the choriocapillaris and CNV in laser scars. PECAM-1 immunohistochemistry is best for detection and quantification of neovascularization in laser scars.
However, therapeutic treatments with a reliable curative effect are not yet available, and therefore several studies have been performed to develop various strategies, including eradication of CNV by laser photocoagulation,1 obstruction of CNV by photodynamic therapy (PDT),2 prevention of angiogenesis by pigment epitheliumderived factor (PEDF),3 and treatment with steroids,4 5 anti-VEGF agents, or an analogue of fumagillin, TNP-470.6
To demonstrate the success or failure of these therapeutic strategies, visualization and quantification of CNV are crucial. Therefore, our study was performed to test and to compare different methods for visualization of experimentally induced neovascularization in the rat by dextran angiography, immunohistochemistry, peroxidase perfusion, and histochemistry.
| Methods |
|---|
|
|
|---|
FITC-Dextran Angiography
Angiography was performed on anesthetized rats generally by the method of DAmato et al.7 and Edelman and Castro.8 Thirty minutes after intraperitoneal injection of 0.5 mL heparin, rats were perfused with 50 mL PBS and 5 mg/mL fluorescein isothiocyanate-labeled dextran (FITC-dextran; MW 2 x 106, Sigma-Aldrich, Deisenhofen, Germany) through a low-perfusion cannula (20-gauge). The physiological blood pressure was maintained by the beating heart and by adjusting the height of the perfusate bottle. Thirty to 90 seconds later, the animals were killed by cervical dislocation. Eyes were enucleated and fixed in 4% paraformaldehyde overnight.
Flatmount Preparation and Digital Images
All flatmounts were prepared as described by McMenamin.9 The eyes were sectioned at the equator, and the anterior half and the vitreous removed. The retinas were isolated and investigated by light microscopy. The posterior eye segment containing the sclera and choroid was dissected into quarters by four radial cuts and mounted on a slide.
All flatmounts described here and later were examined by a fluorescence microscope (Axioplan 2 Imaging; Carl Zeiss Meditec) using FITC, Cy3, and lipofuscin filters (Analysentechnik Feuerbacher, Tübingen, Germany) For FITC: excitation 471 nm, emission 503 nm; for Cy3: excitation 550 nm, emission 570 nm; and for lipofuscin: excitation 405 nm; emission 475 nm. All digital images are taken under the same conditions. The images of the laser scars were captured with an analog video camera (Axioplan 2 Imaging, Carl Zeiss Meditec) coupled to a computer with image-analysis software (Openlab, ImproVision, Inc., Lexington, MA).
Immunohistochemical Visualization of Endothelial Cells
Eyes were enucleated and fixed in 4% paraformaldehyde. Flatmounts were prepared as described. Several of these animals had been perfused by FITC-dextran as described earlier. In the first set of experiments the following immunohistochemical protocol was used. The tissue was labeled with platelet endothelial cell adhesion molecule (PECAM-1; purified rat-anti-mouse CD 31 monoclonal antibody; PharMingen, Heidelberg, Germany) as the primary antibody overnight (dilution 1:100). The secondary antibody was a biotinylated goat anti-rat IgG (Amersham Pharmacia Biotech, Freiburg, Germany), incubated overnight in a dilution of 1:400. The third agent was Cy3-labeled streptavidin (Fluorolink; Amersham Pharmacia Biotech), diluted 1:1000 and incubated for 1 hour at room temperature. In control immunohistochemistry, the primary antibody was omitted. In the next set of experiments, we used purified mouse anti-rat PECAM-1 monoclonal antibody (PharMingen) for specific binding of PECAM-1 (1:200 dilution) and goat anti-mouse IgG conjugated with Cy3 (1:500 dilution; Dianova, Hamburg, Germany) as a secondary detection antibody. As a control, immunostaining was performed without the primary antibody.
Control
Laser scars without dextran perfusion and without immunohistochemical labeling were examined by fluorescence microscopy (FITC-filter).
Histochemical Visualization of Intravasal Peroxidase
Rats were anesthetized and 50 mg horseradish peroxidase (type II, MW 40,000; Sigma-Aldrich) in 200 µL PBS were injected into the jugular vein. Thirty to 90 seconds later, animals were killed by cervical dislocation. The eyes were enucleated, fixed in 1.8% paraformaldehyde and 2% glutaraldehyde in 0.1 M cacodylate buffer (pH 7.4) overnight. Peroxidase was visualized by the method of Karnovsky.10 The anterior part of the eye, vitreous, and retina were removed, and the posterior eye cup was kept in 5 mg 3,3-diaminobenzidine-tetrahydrochloride (DAB; Sigma-Aldrich) dissolved in 10 mL 0.05 M Tris-HCl buffer at pH 7.4. Then, 0.1 mL freshly prepared 30% H2O2 was added. The solution was changed three times for 1 hour each. After the tissue was washed in distilled water, it was postfixed with osmium tetroxide, dehydrated, stained en bloc, embedded in Spurrs resin, and dissected for light microscopy. Ultrathin sections were stained with uranyl acetate and lead citrate and examined by electron microscopy.
Histochemical Visualization of Alkaline Phosphatase in Endothelial Cells
Alkaline phosphatase in endothelial cells was visualized by a method, described by McLeod and Lutty.11 Eyes were enucleated and the posterior half of the eye kept in 0.1% EDTA in Ca2+/Mg2+-free PBS for 2 hours at room temperature. The retina and RPE were removed, and the tissue was washed in 0.1 M cacodylate buffer (pH 7.4) at 4°C. After fixation with 2% paraformaldehyde for 1 hour, the tissues were washed in 0.1 M cacodylate at 4°C overnight. Tissues were incubated with a fresh, filtered solution consisting of 40 mL 0.1 M Tris buffer (pH 9.2) with 20 mg fast blue RR salt (Sigma-Aldrich) and 4 mg naphthol AS-MX phosphate (Sigma-Aldrich) dissolved in 0.2 mL dimethyl sulfoxide (DMSO; Sigma-Aldrich) at 37°C for 30 minutes. After the medium was changed once, the tissue was washed and postfixed at 4° for 24 hours. The tissues were washed and bleached in 30% H2O2 at 4°C for 3 days. The tissues were then repeatedly washed, treated with 1% catalase in 0.1 M cacodylate (pH 7.4; 4°C, 2 hours), and washed again. Radial cuts were made, and the tissues were flatmounted on slides for light microscopy.
| Results |
|---|
|
|
|---|
|
|
FITC-Dextran Angiography
Dextran-perfused vessels were seen regularly at the rim of the laser scars (Fig. 1b) whereas the center of the scars showed diffuse background fluorescence. Even when we focused through the flatmount, the choriocapillaris vasculature could not be demonstrated, either near to or at a distance from the scars. In contrast, flatmounts with overlying retina and separately prepared retinas showed well-perfused retinal vessels.
Immunohistochemical Visualization of Endothelial Cells
Endothelial cells labeled by PECAM-1 were present in the center (Fig. 1c) and at the rim (Fig. 2a) of the laser scars. Circular endothelial cells formed vascular tubes (Fig. 2a) , corresponding to those visualized by dextran angiography (Fig. 1b) . The flatmount in Figure 2a originated from an animal that was perfused by FITC-dextran before labeling with PECAM-1. Therefore, dextran-perfused vessels are also visible at the rim of the scar.
When Figure 1b is compared with Figures 2a and 2b , it becomes clear that only immunohistochemistry provided a clear image of the choriocapillaris vasculature, whereas in dextran angiography the choriocapillaris was not visible.
Control preparations of immunohistochemistry without the first antibody showed no fluorescence (Fig. 1e) . However, the fluorescence signal was made more intense by use of a lipofuscin filter set. In this case, nonspecific fluorescence may be due to the formation of lipofuscin-like material.
Control
In the control, laser scars without any treatment by fluorescent markers (no dextran perfusion, no immunohistochemistry), were examined by fluorescence microscopy with FITC (Fig. 3) and lipofuscin filter sets. Even in these scars, a background fluorescence was present, especially in the center of the scars (Fig. 3 , star). This fluorescence must not be confused with fluorescence expressed in the newly formed vessels. We suggest that this nonspecific fluorescence is due to formation of lipofuscin-like material and/or cell debris derived from damage to the tissue during laser photocoagulation.
|
|
|
Figure 5 is a schematic drawing of a histologic section, showing a laser scar. Retinal neovascularization is distinguished from newly formed endothelial cells in the choroid. Whereas retinal vessels are perfused by peroxidase (Fig. 4a) and dextran (Fig. 1b) , the choriocapillaris vessels are not (Fig. 4a) . Endothelial cells in the choroid, drawn at the bottom of the scar, are visualized by PECAM-1 (Fig. 1c) and electron microscopy (Fig. 4c) . The dotted line indicates the supposed line of separation, when the retina was removed during flatmount preparation.
|
| Discussion |
|---|
|
|
|---|
Argon laser photocoagulation is an established method for generating choroidal neovascularization (CNV) in animal models.12 High laser energy causes rupture of Bruchs membrane, and, under the influence of various angiogenic factors, an ingrowth of choroidal vessels under the RPE and into the subretinal space takes place. Although in this model, pathogenesis of the neovascularization is different from ARMD, formation of CNV is believed to follow the same pattern, and identical angiogenetic factors are expressed by the RPE and endothelial cells: FGF,13 VEGF (Ogata N, et al. IOVS 1996;37:ARVO Abstract 124), and TGF-ß. The energy of the laser affects the appearance of the subsequent scars, however, and has to be taken into account when comparing neovascularization in this model. The laser energy we used was similar to that used by other investigators (e.g., Mori et al.3 ) Mature vessels are present from 10 days after photocoagulation,5 8 and therefore this time was chosen for our experiments.
For the angiography, a high molecular weight dextran (MW 2 x 106) that was bound to a fluorescein marker and did not leak out of the CNV was chosen.7 14 Advantages of dextran angiography examined in flatmounts are the representation of the whole retina and a higher resolution of certain regions,7 as well as the possibility of quantification by measuring the fluorescence. Angiography is faster and easier to perform than histologic methods.
Whereas dextran-perfused vessels were regularly present at the rim of the scars and in the retina 10 days after laser treatment, dextran perfusion of the choriocapillaris was usually not detectable (Fig. 1b) . If the choriocapillaris were perfused, the typical pattern would be the same as that in Figure 2 . Thus, the use of dextran for demonstration of CNV in laser scars in the rat should be regarded cautiously.
In contrast to the choriocapillaris, retinal vessels were always well perfused by dextran, demonstrating that the intravenous injection technique succeeded. Separately prepared retinas demonstrated the same regular perfusion as flatmount preparations with overlying retina. Within the retina, dense networks of vessels were found when focusing through the different planes.
Because the choriocapillaris vessels are not perfused but the retinal vessels are, it is likely that the circular vessels visualized in laser scars by dextran angiography come from the retina. This finding is supported by the results of peroxidase perfusion in the living rat (discussed later).
The background fluorescence in the center of the scars is most likely explained by an autofluorescence due to formation of lipofuscin-like material after laser photocoagulation-induced damage. This is indicated by laser scars showing autofluorescence without dextran perfusion. Under the FITC filter it can be seen as green-orange fluorescence.
For the demonstration of vessels within laser scars as well as the choriocapillaris vasculature, immunohistochemical staining with a PECAM-1-antibody, a classic marker for endothelial cells,15 is more helpful. PECAM-1 is an integral membrane protein on endothelial cells that mediates cell-to-cell adhesion.
In accordance to the results of dextran angiography, vessel-forming endothelial cells in laser scars were present, predominantly at the margin (Fig. 2a) , but there were also flat endothelial cells in the middle of the scars. Measurement of the fluorescence signal makes it possible to obtain a semiquantitative evaluation of the vascularization. However it should be performed under the same conditions and the same physiological state. In contrast to the angiography, the endothelial cell marker gives a detailed picture of the choriocapillaris vasculature (Figs. 2a 2b) . This is also true of staining with alkaline phosphatase, a membrane-bound enzyme of endothelial cells,16 with which a good representation of neovascularization surrounding the laser scars (Fig. 6a) as well as the choriocapillaris vasculature (Fig. 6b) , is possible. We did not observe the variation in enzyme expression and intense background staining that have been cited as objections to this technique.7
To get a clearer picture of the regions of interest, histologic techniques were used (Fig. 4) . The tight connection between the retina and RPE and therefore the choroid after laser treatment, in addition to the sinking of retinal structures toward the choroid, makes it comprehensible that within the area of the laser scar parts of the retina may adhere to the flatmount (compare Fig. 2a ) when the retina is stripped off. The dotted lines in Figures 4a and 5 indicate the line of separation. This explains also the small patches of retinal tissue beneath the laser scar in Figure 2a . The enzyme product of intravenous injected peroxidase is visible as a black reaction product in the retinal vessels, whereas the choriocapillaris is not perfused in the same section (Figs. 4a 4b) . Peroxidase perfusion does not go beyond the large choroidal arterioles which appear to be constricted (Fig. 4a , arrowhead). Thus, the perfused vessels at the rim of the laser scars more likely originate from the retina rather than the choroid.
Generally peroxidase penetrates out of capillaries through transcytosis and intercellular clefts between endothelial cells. In our study, however, animals were killed before extravasation could take place, which was confirmed by electron microscopy.
In the center of the scars, flat endothelial cells were seen by light and electron microscopy which seemed not to form vascular tubes (Figs. 4a 4c 5) . These cells were located within the choriocapillaris and correspond most likely to the endothelial cells in Figure 1c , shown in the center of the scars by immunohistochemistry. These cells are not visualized by dextran angiography. They are probably not arranged as vascular tubes with lumens, or they may be part of the choriocapillaris, which was not perfused by FITC-dextran. It is also possible that these endothelial cells are within the original walls of the choriocapillaris, representing a repair process. Hypertrophied, hyperosmotic endothelial cells with reduced lumina are reported as a feature of capillaries in injured tissue.17 These cells are thought either to come from the choroid or to derive from circulating precursors.18 Thus, experimentally induced neovascularization in laser scars may originate from choroidal and retinal vasculature, as outlined in the schematic drawing in Figure 5 .
The explanation for nonperfusion of the choriocapillaris, even distant from the laser spots is not clear. Because the eyes were enucleated only 30 to 90 seconds after injection, the markers could not have already left the choriocapillaris. Because the retina was perfused, it can be excluded that the eyes were enucleated before choroidal filling. Laser photocoagulation influences the perfusion of the surrounding the choriocapillaris by capillary occlusion,19 and, as a result, perfusion of noncoagulated fundus areas should improve. This was not seen in our experiments, which showed no peroxidase-perfused vessels in the choriocapillaris, even at a distance from the laser spots. It has been reported that high molecular weight labels such as horseradish peroxidase and FITC can influence vascular transport20 ; however, the retinal vessels were well perfused and showed no signs of obstruction.
Leakage of peroxidase out of the choriocapillaris was excluded by electron microscopic examination; leakage of dextran can be ruled out because of its high molecular weight.7 14
Another explanation could be that anesthesia influenced the choriocapillaris perfusion. Differences in blood flow regulation between retinal and choroidal microvasculature are known21 for example, the role of NO in vascular autoregulation or the influence of varying intraocular pressures.22 23
Whatever the reason for this nonperfusion of the choriocapillaris, the following conclusion can be drawn independently: When creating laser-induced neovascularization in an animal model of CNV, the observed vessels not only originate from the choroid, but also from the retina. When dextran angiography represents retinal vessels and not choroidal vessels, the relevance of this model as a model of ARMD has to be reconsidered.
Although different conclusions may be reached by other protocols, of the four tested methods used in these studies, the most useful and time saving was the immunohistochemical staining of endothelial cells by PECAM-1. The use of more than one method (for example FITC-dextran angiography and PECAM-1 immunohistochemistry) can contribute to better characterization and evaluation of vascularization after laser photocoagulation.
| Footnotes |
|---|
Submitted for publication July 18, 2002; revised November 20, 2002, and February 19, 2003; accepted February 28, 2003.
Disclosure: I. Semkova, None; S. Peters, None; G. Welsandt, None; H. Janicki, None; J. Jordan, None; U. Schraermeyer, None
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be marked "advertisement" in accordance with 18 U.S.C.
1734 solely to indicate this fact.
Corresponding author: Irina Semkova, Center for Ophthalmology, Department of Vitreo-Retinal Surgery, Joseph-Stelzmann-Str. 9, D-50931 Cologne, Germany; irina.semkova{at}medizin.uni-koeln.de.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
C. Campa, I. Kasman, W. Ye, W. P. Lee, G. Fuh, and N. Ferrara Effects of an Anti-VEGF-A Monoclonal Antibody on Laser-Induced Choroidal Neovascularization in Mice: Optimizing Methods to Quantify Vascular Changes Invest. Ophthalmol. Vis. Sci., March 1, 2008; 49(3): 1178 - 1183. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Olson, R. J. Courtney, and N. Mandava Intravitreal Infliximab and Choroidal Neovascularization in an Animal Model Arch Ophthalmol, September 1, 2007; 125(9): 1221 - 1224. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Campos, J. Amaral, S. P. Becerra, and R. N. Fariss A Novel Imaging Technique for Experimental Choroidal Neovascularization Invest. Ophthalmol. Vis. Sci., December 1, 2006; 47(12): 5163 - 5170. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Semkova, S. Fauser, A. Lappas, N. Smyth, N. Kociok, B. Kirchhof, M. Paulsson, V. Poulaki, and A. M. Joussen Overexpression of FasL in retinal pigment epithelial cells reduces choroidal neovascularization FASEB J, August 1, 2006; 20(10): 1689 - 1691. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Imamura, S. Noda, K. Hashizume, K. Shinoda, M. Yamaguchi, S. Uchiyama, T. Shimizu, Y. Mizushima, T. Shirasawa, and K. Tsubota Drusen, choroidal neovascularization, and retinal pigment epithelium dysfunction in SOD1-deficient mice: A model of age-related macular degeneration PNAS, July 25, 2006; 103(30): 11282 - 11287. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Yeh, D. V. Bula, J. W. Miller, E. S. Gragoudas, and J. G. Arroyo Expression of Leukocyte Adhesion Molecules in Human Subfoveal Choroidal Neovascular Membranes Treated with and without Photodynamic Therapy Invest. Ophthalmol. Vis. Sci., July 1, 2004; 45(7): 2368 - 2373. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |